To characterize the retinal histopathology in carriers of X-linked progressive retinal atrophy (XLPRA1 and XLPRA2), two canine models of X-linked retinitis pigmentosa caused, respectively, by a stop and a frameshift mutation in RPGR-ORF15.
and, more commonly, rod-cone degenerations. 11 Males affected with RPGR-XLRP typically exhibit night blindness in the first decade of life, followed by reduction of the visual field and loss of central visual acuity. By the end of the fourth decade, most patients are legally blind. 12 Female carriers, on the other hand, display a broad spectrum of disease severity. The age of onset and the extent of fundus pigmentary changes, visual field defects and ERG abnormalities vary considerably between and within families. 11, [13] [14] [15] A characteristic of female XLRP carriers is the patchy nature of the disease expression when assessed by funduscopic examination, Goldmann perimetry, 11, 16 multifocal ERG, 17 and histopathology. 16,18 -20 This mosaic of normal and diseased retinal foci is best explained by Lyon's hypothesis of random X-chromosome inactivation that occurs at an early stage of female embryogenesis. 21 Histopathologic reports of the retinal lesions in XLRP carriers are scarce. Indeed, they are limited to that of four individuals, three of them carrying mutations in RPGR. 16,18 -20 Since these studies were conducted on postmortem retinas of older (Ͼ75 years of age) patients, the findings represent histologic alterations observed at an advanced stage of disease. For obvious reasons, access to retinal tissues from younger patients is likely to be even more limited and currently hampers our understanding of the course of the disease in XLRP carriers. The use of animal models with naturally occurring forms of X-linked retinal degeneration represents a valuable tool for examining whether, in carriers, the mosaic pattern of degenerating and normal retinal foci remains unchanged or not throughout the course of disease.
In the dog, two distinct forms of X-linked retinal degeneration, termed XLPRA1 and XLPRA2, have been characterized, and are caused, respectively, by a stop and a frameshift mutation in RPGR exon ORF15. 22 The frameshift mutation causes an early and severe loss of photoreceptors (XLPRA2) that begins a few weeks after birth, while the stop-mutation disease (XLPRA1) has a later onset (ϳ11 months of age) and more gradual progression. [22] [23] [24] In both diseases, multiple patches of degeneration have been reported in carriers. 22, 24 In the present study, we have expanded the analysis of the retinal mosaic in XLPRA1 and XLPRA2 heterozygotes and find focal lesions of photoreceptor disease and degeneration similar to The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
those observed throughout the retinas of homozygotes. In addition, we report that the retinal mosaic disease pattern changes as a function of age in XLPRA2 carriers, whereas no such retinal plasticity occurs in carriers of the later onset XLPRA1 disease.
MATERIALS AND METHODS

Animals
Twelve dogs were used in the study: 10 crossbred female XLPRA2 carriers (age range: 3.9 weeks to 10.3 years), and 2 crossbred female XLPRA1 carriers (age: 20 and 24 weeks). All dogs were bred at the Retinal Disease Studies Facility (RDSF, University of Pennsylvania, New Bolton Center, Kennett Square, PA), and their genotype was determined either from the known status of their progenitors or from genetic testing for the disease-causing mutation. 22 All animals were anesthetized by intravenous injection of pentobarbital sodium, the eyes were enucleated, and then the dogs were euthanatized. All procedures involving animals were in compliance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. In addition to the 12 dogs that were specifically bred for this study, archival retinal sections from 7 older carriers of XLPRA1 (age range: 1.4 -7.8 years) were included (Table 1) . No experiments with tissues from wild-type (i.e., nonmutant) dogs were repeated in the present study as they had already been performed and reported in a previous publication.
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Retinal Histology
The left eyes of eight of the XLPRA2 carriers were used for morphologic examination of disease expression after plastic or optimal cutting temperature (OCT) compound embedding (Table 1 , morphology). The tissues were processed for plastic embedding as previously reported, according to a similar protocol as was used for the archival tissues from seven XLPRA1 carriers. 25 After enucleation, the globes, and then the posterior segments, were isolated and fixed after a sequential triple fixative protocol (3% glutaraldehyde-2% formaldehyde; 2% glutaraldehyde-1% osmium tetroxide; and 2% osmium tetroxide). The posterior segments were then trimmed into pieces that extended from the optic nerve head to the ora serrata along the superior and inferior meridians, dehydrated, and embedded in epoxy resin (PolyBed 812; Polysciences, Warrington, PA). The tissues were sectioned with glass knives at 1 m with a microtome (2065 Reichert Jung Supercut; Leica, Deerfield, IL), stained with azure II-methylene blue with or without a paraphenylenediamine (PPDA) counterstain.
Sections from both the superior and inferior meridians were examined with a 40ϫ objective by light microscopy (Axioplan; Carl Zeiss Meditec, Oberkochen, Germany). The sections were examined in contiguous fields from the optic disc to the ora serrata, including evaluation of the retinal pigment epithelium (RPE), the rod and cone outer (OS) and inner (IS) segments, and the thickness and density of the outer nuclear and inner nuclear layers (ONL and INL). Quantitative measurements of the ONL were made in XLPRA2 carriers in the central (site S1: 2000 Ϯ 500 m from the optic nerve head), peripheral (site S3: 2000 Ϯ 500 m from the ora serrata), and mid-peripheral (site S2: midpoint Ϯ500 m between the optic nerve head and the ora serrata) regions. As most archival sections from the XLPRA1 carriers did not contain either the optic nerve head or the ora serrata, the measurements were made at the extremities of the section and referred to as central and peripheral retina.
TUNEL Assay
In the eight XLPRA2 and two XLPRA1 carrier dogs, one eye was processed to perform TUNEL assays and/or immunohistochemistry (IHC: TUNEL, Table 1 ). After enucleation, a slit was made through the globe at the level of the ora serrata, and the entire globe was fixed in paraformaldehyde, cryoprotected, and embedded in OCT medium as previously reported. 23 Cryosections (7 m thick) along the superior meridian were used for TUNEL assay according to the manufacturer's protocol (In Situ Cell Death Detection kit; Roche, Indianapolis, IN), and stained with DAPI. Positive controls included sections pretreated with DNase I (3 U/mL in 50 mM Tris-HCl [pH 7.5] and 1 mg/mL BSA) for 10 minutes at room temperature. For negative controls the terminal transferase enzyme was omitted from the TUNEL reaction mixture. Sections were examined from the optic disc to the ora serrata by epifluorescence microscopy with the 40ϫ objective. TUNEL-labeled cells in the ONL were counted throughout the entire length of the section (i.e., from disc to ora serrata). To determine the proportion of photoreceptor cells that undergo cell death as a function of time, we expressed our results as the number of TUNEL-labeled photoreceptor cells per 10 6 m 2 of ONL as previously reported. 23 The area of the ONL of each section was obtained by measuring the entire length of the ONL from optic disc to ora serrata and multiplying it by the average thickness of the ONL throughout the section (mean value of the thickness measured in the three locations reported above). If focal thinning was present at the site, the closest adjacent site that was representative of the ONL thickness was measured. In areas of decreased photoreceptor density, this method may slightly underestimate the proportion of cells that are TUNEL positive, but was selected because individual cell counts could not be determined on 7-m-thick DAPI-stained cryosections. For each dog, this assay was performed in triplicate with sequential sections from the superior meridian. The results were averaged and reported as the mean Ϯ SD.
Immunohistochemistry
Cryosections made along the superior retinal meridian of the eight XLPRA2 and two XLPRA1 carrier dogs were processed as described and were used for fluorescence IHC. We used a battery of cell-specific antibodies, most of which already have been shown to specifically label the canine retina (Table 2) . 23 Since previous testing of the RPGR and RPGRIP antibodies conducted in our laboratory failed to show any cross-reactivity or specificity on the dog retina, we did not include them in the study. 22 Cryosections (7-10 m thick) were incubated Confocal microscopy was also used on a subset of sections to image discrete structural changes occurring in the outer segments. The confocal images were acquired on a tunable confocal (TCS-SP5; Leica Microsystems, Wetzlar, Germany) and MP system with an upright microscope (DM 6000 CFS; Leica Microsystems) through a 40ϫ oil lens (NA ϭ 1.25). The specimens were excited at 488 nm supplied by an Argon laser. DAPI was excited with multiphoton at 720 nm produced by a Ti:sapphire pulse laser (Chameleon Ultra II; Coherent, Santa Clara, CA).
RESULTS
Multifocal Retinal Degeneration
Retinal Histopathology of XLPRA2 Carriers. At 3.9 weeks of age, no morphologic abnormalities could be seen in the maturing photoreceptors (Fig. 1A) . The earliest alterations that could be detected by 4.9 weeks of age on 1-m-thick plastic sections consisted of patchy areas of OS misalignment and disruption resulting in a weaker PPDA staining (Fig. 1B) ; occasional pyknotic nuclei also were seen. At 5.9 weeks, there was more prominent OS disorganization that resulted in a clearer demarcation between diseased and nondiseased foci (Fig. 1C) . In diseased areas, rod cell density was decreased, yet consistently there was an increase in ONL thickness due to an increase in internuclear distance. By 26.1 weeks of age ( Fig.  1D 1 ) , there was a generalized thinning of the ONL. Patches of disease surrounded by structurally normal retina persisted, but they appeared to be fewer and of smaller size (Figs. 1D 2 , 1D 3 ). This was even more obvious by 39 weeks of age. In older dogs (8.8 and 10.3 years) multifocal patches were rarely found, but endstage peripheral retinal atrophy that extended toward the mid-peripheral region was observed (Table 3) . Differences were observed between the two aged dogs both in the location and the extent of the retinal damage. In the 8.8 year-old dog, severe peripheral retinal damage (total atrophy to one to two rows of nuclei in the ONL) was seen in the superior region extending up to 7000 m from the ora serrata. The central retina had a thin ONL (four rows of nuclei), and the photoreceptors had enlarged and short IS, but maintained their OS. Inferiorly, severe retinal damage (0 -2 rows of nuclei) was seen throughout the entire retinal section. No OS were visible inferiorly, and the RPE was either directly apposed to the external limiting membrane (ELM) or to shortened IS. In the 10.3-yearold dog the peripheral and mid-peripheral regions of the retina were also severely affected, yet photoreceptor loss was more prominent superiorly than inferiorly (Figs. 1E 1 -E 3 ).
Retinal Histopathology of XLPRA1 Carriers. Examination of H&E-stained cryosections from a 20-and 24-week-old XLPRA1 carrier did not reveal any morphologic alterations compatible with an ongoing disease process (Figs. 2A 1 -A 3 ). The earliest age at which foci of disease were found was at the next time point, 1.4 years. These were observed throughout the retinal length and characterized by a local loss of OS and a decrease in rod density and ONL thickness (Figs. 2B 1 -B 3 ). Beginning at 4.9 years of age and increasing with time, foci of increased cone density and rod loss were seen throughout the length of the retina (Figs. 2C 1 -C 3 ). Similar to that reported in affected animals, 24 substantial differences in disease severity were observed between carrier dogs of similar ages (e.g., dogs H6 and H74; Table 4 ).
Immunohistochemical Characterization of Retinal Disease in XLPRA Carriers
Multifocal Retinal Disease in XLPRA2 Carriers. Cellspecific markers for rods and cones were tested to determine whether they were differentially expressed in normal and diseased areas of the retina (Fig. 3) . Immunolabeling with rod opsin revealed alterations as early as 3.9 weeks of age that were similar to that previously reported in affected animals. 23 These consisted of rod opsin mislocalization to the IS and ONL, and rod neurite sprouting (Fig. 3A 1 ). However, in the case of the carrier dogs examined in this study, these abnormalities had a multifocal distribution that overlapped with the areas of ONL thickening. DAPI labeling confirmed that areas of increased ONL thickness corresponded to areas of diseased rods (Fig.  3A 2 ). At 39 weeks of age the number of patches of rod opsin mislocalization and ONL thickening were considerably reduced (Figs. 3B 1 , 3B 2 ). By confocal microscopy, we also confirmed that in those regions in which opsin was mislocalized and the ONL thickened, rod OS were misaligned and disorganized (Figs. 3C 1 , 3C 2 ). Since cone opsins have been shown to mislocalize during the early phase of the disease in affected XLPRA2 dogs, we investigated whether this also occurs in carriers (Fig. 4) . Double immunolabeling with rod opsin and M/L opsin antibodies showed mislocalization of M/L cone opsin in young animals (3.9 -12 weeks of age) in the same retinal patches where rod opsin was mislocalized (Figs. 4A 1 , 4A 2 ) . A peculiar finding that was detected as early as 5.9 weeks of age was the increased density of M/L cones in the patches where rod opsin was mislocalized (Figs. 4C 1 -C 3 ) A similar observation was made in cones labeled with human cone arrestin antibody (data not shown). In older animals (39 weeks), patches of M/L opsin mislocalization persisted despite a decrease in rod opsin mislocalization. Thus, there were fewer patches of rod opsin mislocalization than patches of M/L cone opsin mislocalization (data not shown), suggesting a possible loss of mutant rods and the persistence of diseased cones. The temporal pattern of S opsin labeling was slightly different since mislocalization, which also occurred in the areas where rod opsin mislocalized (Figs. 4B 1 , 4B 2 ), was rarely seen after 12 weeks of age. No clumping of S cones was seen as with M/L cones. This finding was not surprising, since there as fewer S cones than M/L cones in the canine retina.
At 26.1 weeks of age, phagocytic cells were frequently seen in the subretinal space of the degenerating patches, but not in the surrounding intact areas. Double immunolabeling with RPE65 and CD18 antibodies demonstrated that these cells were macrophages rather that detached RPE cells migrating into the subretinal space (Figs. 5A , 5B).
Because photoreceptor degeneration in affected XLPRA2 dogs is associated with inner retinal remodeling, we investigated whether focal retinal disease alters the underlying inner retina in XLPRA2 carriers. PKC␣ and Go␣ labeling showed a retraction of the dendrites of rod bipolar cells that synapsed with the diseased rods (Fig. 6A 1 , asterisks) . GABA (␥-amino butyric acid) IHC, which was used to label GABAergic amacrine cells as well as the inner plexiform layer (IPL), did not show any focal alterations in the areas of photoreceptor disease in either young or older animals (data not shown). Müller cell reactivity, which was evidenced by intense GFAP labeling, occurred in the patches of photoreceptor disease as early as 8 weeks of age and was still intense at 12 weeks (Figs. 6B 1 , 6B 2 ) . At 26.1 weeks of age, radial extensions of GFAP labeling were considerably reduced, and by 39 weeks labeling was limited to (Fig. 7) .
Although rod neurite sprouting was clearly visible, we did not observe a thickening of the ONL at the sites of disease as in the XLPRA2 carriers. It is important to note that mislocalization of rod and M/L cone opsins occurred at an age when there are no structural abnormalities visible in the retina by light and electron microscopy in hemizygous males. 24 S opsin mislocalization was seen in both animals but was limited to the peripheral retina (data not shown). No abnormal pattern in PKC␣ or Go␣ labeling was observed either, and GFAP labeling was limited to astrocytes and Müller cell end feet (data not shown).
Kinetics of Photoreceptor Cell Death
A TUNEL assay was performed on XLPRA2 carrier retinas to determine the course of photoreceptor cell death. Quantification of TUNEL-labeled photoreceptors in XLPRA2 carriers showed a similar burst of cell death at 5.9 weeks of age (241-302 TUNEL-labeled cells per 10 6 m 2 of ONL) as previously reported in affected XLPRA2 dogs (Fig. 8A and (The labeling of the inner retina with the M/L opsin antibody was not specific, and the yellow in the cone OS was the result of a postacquisition increase in the green signal of the overlay image, to improve visualization of the rod opsin mislocalization; it does not represent colocalization). In a 5.9-week-old XLPRA2 carrier, faint S opsin mislocalization to the inner segments and ONL was seen in some cones (arrows; B 1 ). These cones are located within patches of rod opsin mislocalization (B 2 ). Immunolabeling in a 5.9-week-old XLPRA2 carrier showed an increased density in M/L cones in the patches of rod and M/L opsin mislocalization (C 1 -C 3 ) . (D 1 ) Plastic-embedded retinal section from a 26.1-week-old XLPRA2 carrier showed focal accumulation of large euchromatic nuclei resembling that of cones in an area of rod loss. (D 2 , D 3 ) Double-fluorescence IHC in a 39-week-old XLPRA2 carrier showed increased density of cones that was either distributed in a monolayer (D 2 ) or clumped together (D 3 ). There was no rod opsin mislocalization in the patches of increased cone density. Scale bars: (A 1 , A 2 , B 1 , B 2 , C 2 , C 3 , D were counted. To confirm that cell death was occurring within the foci of retinal disease, we examined sections that were TUNEL-labeled and processed for rod opsin IHC. TUNEL-positive photoreceptors were only found in areas where rod opsin was mislocalized to the ONL (Fig. 8B ). In the 20-and 24-weekold XLPRA1 carriers, a limited number of TUNEL-labeled rods were observed and were restricted to the foci of rod opsin mislocalization (Fig. 8C) .
Remodeling of the Retinal Mosaic in XLPRA2 Carriers
Evident thinning of the ONL was seen in older carriers of XLPRA2, and, in addition, there also seemed to be fewer disease patches (Fig. 9) . To further substantiate the observation that the retinal mosaic appeared to remodel in the young adult dog, we determined the proportion of retinal length that was occupied by foci of retinal degeneration as a function of age. This appraisal was performed, when possible, on sections from both the superior and inferior meridians. Fig. 9C ). Further reduction in ONL thickness in a 10.3 year-old carrier suggests that rare events of photoreceptor cell loss persist beyond the 39-week time point (Fig. 9C) . Immunohistochemistry confirmed these results by showing that in animals older than 26 weeks of age there was a significant decrease in the number and size of the patches of rod opsin mislocalization (compare Fig. 3B 1 with 3A 1 ). It also confirmed that the ONL was thinner but appeared more uniform in older animals (compare Fig. 3B 2 with Fig. 3A 2 ) . In older animals, the cone mosaic remained irregular, and focal areas of increased cone density were frequently found (Fig. 4D 1 ) . As early as 12 weeks of age, some of these patches of high cone density were characterized by the clumping of the cell somas, which often resulted in multiple layers of cones in the ONL (Figs. 4D 2 , 4D 3 ).
In the inner retina, the number of patches of dendritic retraction followed a similar time course as that of the patches of rod opsin mislocalization. By 39 weeks of age, these had become very rare, and most of the bipolar cells had a normal appearance (compare Fig. 6A 2 with 6A 1 ) .
No such remodeling of the retinal mosaic was seen in young XLPRA1 carriers, which express a later onset and more progressive form of the disease.
DISCUSSION
A single report on the use of multifocal electroretinography in carriers of XLRP has shown that these patients experience a mosaic pattern of retinal dysfunction. 17 A similar multifocal pattern of disease has been confirmed by several histologic observations of retinas from older heterozygotes. 16,18 -20 The present study examined the retinas in carriers of two canine models of RPGR-XLRP, and showed significant changes (sum- 6. Disease and remodeling of the inner retinal mosaic in carriers of XLPRA2 at 7.9 and 39 weeks of age. Double-fluorescence IHC in a 7.9-week-old XLPRA2 carrier showed focal dendritic retraction of rod bipolar cells (yellow) beneath the patches of rod opsin mislocalization (✽; A 1 ). Absence of rod bipolar dendritic retraction was noted in the 39-week-old XL-PRA2 carrier (A 2 ). (B 1 , B 2 ) GFAP IHC in a 7.9-week-old XLPRA2 carrier showed patchy labeling of the radial extensions of reactive Müller cells (B 1 ). Double IHC confirmed that these GFAP labeled radial extensions occurred in Müller cells located beneath the larger patches of rod opsin mislocalization (B 2 ). Scale bars: (A 1 , A 2 ) 20  m; (B 1 , B 2 ) 40 m.
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Retinal Remodeling in Carriers of RPGRORF15 Mutations 3991 marized in Table 5 ) in the appearance of the retinal mosaic as a function of age, particularly in the early onset model. These remodeling events suggest that the young adult canine retina retains some degree of morphologic plasticity. In carriers of XLPRA2, the time of disease onset was similar to that previously reported in affected animals (ϳ4 -5 weeks of age) and was also followed by a burst of rod cell death at 6 to 7 weeks of age. This further confirms our conclusion 23 that a model of constant or exponentially decreasing risk of cell death 26 does not apply to the kinetics of photoreceptor degeneration in XLPRA2.
Surprisingly, the peak count of TUNEL-positive cells in heterozygotes was very close to that in affected animals (female homozygotes and male hemizygotes), both in timing and amplitude. In the context of random X-chromosome inactivation, we expected that this value would be approximately 50% of that in affected dogs. This finding may, therefore, reflect the occurrence of primary skewed X-inactivation, a process that has been implicated in female carriers with X-linked mental retardation disorders and hemophilia A (for review, see Ref. 27) . A noteworthy observation is that counts of TUNEL-positive cells in affected and carrier animals were similar but only at the time of occurrence of the peak of cell death. Indeed, at later time points, values in carriers were ϳ50% of that reported in affected dogs. Thus, an alternative explanation could be that "mutant" photoreceptors undergoing degeneration may cause, through a bystander effect, the death of neighboring "normal" photoreceptors that are expressing the wild-type allele. Such a non-cell-autonomous mechanism of degeneration has been suggested to occur in the chimeric retina of a transgenic mouse line expressing both wild type and mutant (P347S) rhodopsin. 28 This degeneration may be caused by the release of a diffusible apoptosis-promoting factor. 29 If so, during the burst of photoreceptor death, there may be involvement of both intrinsic (mutation dependent) and extrinsic (toxic/apoptotic inducing factors) mechanisms of cell death.
When comparing the histopathologic patterns between the XLPRA1 and XLPRA2 carriers, we noted that the mosaic gradually disappeared in XLPRA2 between 4.9 and 39 weeks of age, whereas it persisted, until at least 7.8 years of age, in XLPRA1. This time course may correlate with the time of onset of degeneration in these two diseases (XLPRA2: early onset; XLPRA1 late onset), and the ability of the retina to undergo a "corrective" remodeling event. We hypothesize that this remodeling may occur in the XLPRA2 carrier retina through tangential dispersion of photoreceptors expressing the wildtype RPGR allele into the degenerating patches. Such an event may only occur during the short time window that follows photoreceptor maturation in the dog and may no longer be present in the nonplastic adult retina such as that of a 1.4-yearold XLPRA1. It is to be determined whether postdevelopmental tangential dispersion of photoreceptors also occurs in human carriers of XLRP, as this may have practical implications for corrective gene therapy. Indeed, if rods and cones have the capacity to move to neighboring regions of diseased retina, then there is a risk that a treated region may end up being depleted of its rescued photoreceptors to the benefit of surrounding nontreated areas. This could have applications for the treatment of carriers of XLRP by opting for panretinal rather than localized delivery of the gene therapy construct.
The early-onset and rapidly progressing disease that occurs in carriers and affected XLPRA2 dogs (homozygous females and hemizygous males) is thought to result from a toxic gain of function. The two nucleotide deletion (del1084-1085) in RP-GRORF15 causes a frameshift that modifies significantly the amino acid sequence by adding 34 basic residues, increases the isoelectric point, and prematurely terminates translation 71 amino acids downstream. 22 The five nucleotide deletion (del 1028-1032) in XLPRA1 introduces a premature stop codon that truncates the RPGROR15 isoform from its 230 C-terminal amino-acids and slightly decreases the isoelectric point. 22 The current hypothesis is that this leads to a loss of function of RPGRORF15, and that this isoform may not be critical for retinal development and maturation. A similar correlation between disease phenotype and individual mutations in RPGR has been reported in two mouse models of RPGR-XLRP. 30, 31 Besides the difference in the severity and time course of the patchy degeneration, XLPRA1 carriers differed from XLPRA2 carriers by exhibiting variation in disease severity at similar ages. This has also been found in XLPRA1-affected hemizygous male dogs 24 and is most likely caused by the effect of modifier genes. No such modifiers have yet been identified; however, the candidate genes RPGRIP1, RANBP2, NPM1, PDE6D, NPHP5, and ABCA4 have been excluded. 32 A question that was not addressed in the present study is whether the remodeling of the cytoarchitecture of the carrier retina is paralleled by some functional plasticity. By 39 weeks of age, despite a loss of ϳ50% of rods, the lamination of the ONL and the morphology of rod bipolar cells appear to have recovered from the earlier phase of multifocal degeneration. This potentially suggests that rewiring of second-order neurons to surviving (nonmutant) photoreceptors can occur. Assessing whether structural recovery leads to a period of improved retinal function is a worthwhile subject for future investigation.
Several immunohistochemical and morphologic alterations observed in both the XLPRA1 and XLPRA2 carrier dogs have also been reported in human patients. 33, 34 This includes the mislocalization of rod and cone opsins 16, 19, 20 which may underline the putative role of the RPGRORF15 isoform in trafficking proteins from the IS to the OS. Double fluorescent IHC showed that mislocalization of rod and cone opsins occurred within the same patch of disease. This finding was unexpected since, during retinal development, rods and cones that are clonally derived from the same photoreceptor progenitor cell have a different pattern of dispersion. Rods get distributed along a radial column whereas cones are tangentially dispersed. 35, 36 The mislocalization of cone and rod opsins within the same patch could be explained by a defective developmental tangential dispersion of cones expressing the mutant RPGR allele. Alternatively, cone opsin mislocalization may be the consequence of a toxic bystander effect of the surrounding "mutant" rods on cones that express the wild-type RPGR allele. The lack of an antibody raised against the mutant canine RPGR isoforms currently precludes us from further investigating this question.
Another common finding that was observed in RPGRORF15 carrier dogs and in a human patient is the focal aggregation of cones. 19 This was easily recognized in older animals and was often the only remaining histologic criteria that could be used to define a patch of disease. Careful examination of the cone distribution showed an increased density of cones in the patches of disease as early as 5.9 weeks of age. In XLPRA2, a "corrective" remodeling phase follows the initial burst of cell death, and leads to preserved retinal lamination despite a loss of approximately 50% of the rods by 39 weeks of age. However, this event is only transient and topographically restricted as large regions of degeneration/atrophy are found in the peripheral and mid-peripheral retina of older animals. A similar topographical distribution has been described in a human carrier. 19 Several mechanisms that are not mutually exclusive could explain this persistent loss of photoreceptors, and its regional predilection. It has recently been reported that in human fibroblasts at least 15% of all X-linked genes can escape random X chromosome inactivation. 37 This secondary skewing of X inactivation has been shown to be associated with aging, although it is likely to be species-, tissue-, and locus-specific. 38, 39 Thus, it is possible that in older carriers of XLPRA2, reactivation of the silenced mutant RPGR allele leads to a second wave of photoreceptor death. Another potential explanation is that there is a minimal number of rows of photoreceptors necessary to sustain viability of these cells. If such is the case, then gradual thinning of the ONL throughout the retinal surface is bound to have a more severe impact on peripheral regions where the ONL is several rows of ONL thinner than centrally. Finally, this late phase of peripheral degeneration could also be explained by the generation of new photoreceptors from progenitor cells located at the retinal margin. Several reports have suggested that this mechanism of photoreceptor renewal may not be limited to fish, amphibians, and birds, but also may be found in mammals. 40 If this is the case in the canine retina, then newly formed photoreceptors expressing the mutant RPGR allele would not only undergo cell death but could also cause a detrimental bystander effect on nonmutant photoreceptors located in the peripheral retina.
A significant finding of this study is that the morphologic appearance of the retinal mosaic changes with time and, as a consequence, so do the histologic criteria used to define patches of degeneration. This effect was clearly observed in XLPRA2, and may also occur in human carriers of early-onset forms of XLRP. The clinical implication of the remodeling events that occur in the carrier retina is that, depending on the stage of the disease, it may be challenging to diagnose, both in animal models and human patients, the mosaic pattern via in vivo imaging techniques such as optimal coherence tomography. In the case of XLPRA2, OCT imaging in a 5.9-week-old carrier would identify foci of increased and decreased ONL thickness corresponding respectively to patches of diseased and normal retina. On the other hand, examination at later stages would not show any mosaicism and would probably reveal either normal retinal lamination with generalized and uniform thinning of the ONL (e.g., 39 weeks of age), or prominent and extended retinal thinning with loss of lamination in the peripheral retina of much older animals (e.g., 10.3 years of age).
In summary, characterization of the morphologic changes that occur in the carrier retina of two canine models of XLRP established that prominent remodeling events occur throughout the course of the disease and demonstrated that the retinal mosaic shows a dynamic and evolving response pattern. It also supports the evidence that heterozygotes for RPGR-XLRP mutations may experience severe visual impairment. 19, 41 These results provide new insight to gene therapy approaches that can be used in both affected and carrier retinas. 
